Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia / Takashi Okada en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 5 (Octubre) . - pp. 441-447 Título : Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia Tipo de documento: texto impreso Autores: Takashi Okada, Autor ; Motomi Toichi, Autor ; Morimitsu Sakihama, Autor Fecha de publicación: 2023 Artículo en la página: pp. 441-447 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antiparkinsonianos, Antagonistas colinérgicos, Pruebas de función cardíaca, Trastornos parkinsonianos, Trastornos psicóticos. Resumen: The arguments against the use of anticholinergic antiparkinsonian drugs for neuroleptic-induced parkinsonism have been based, in part, on their autonomic side effects. Except for anecdotal case reports, there is little evidence that antiparkinsonian drugs are the main factor causing autonomic dysfunction in schizophrenic patients with parkinsonism. Link: ./index.php?lvl=notice_display&id=30996 [artículo] Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia [texto impreso] / Takashi Okada, Autor ; Motomi Toichi, Autor ; Morimitsu Sakihama, Autor . - 2023 . - pp. 441-447. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 5 (Octubre) . - pp. 441-447 Palabras clave: Antiparkinsonianos, Antagonistas colinérgicos, Pruebas de función cardíaca, Trastornos parkinsonianos, Trastornos psicóticos. Resumen: The arguments against the use of anticholinergic antiparkinsonian drugs for neuroleptic-induced parkinsonism have been based, in part, on their autonomic side effects. Except for anecdotal case reports, there is little evidence that antiparkinsonian drugs are the main factor causing autonomic dysfunction in schizophrenic patients with parkinsonism. Link: ./index.php?lvl=notice_display&id=30996

---

1 (1 - 1 / 1)